Alpha Tau Medical Ltd. Warrant (DRTSW)
Stock · NASDAQ · Health Care
$2.43as of 10/16/2026
Price chart
Active signals
High Beta85.6%
Resistance level
$3.78
Industry
Medical/Dental Instruments
About DRTSW
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 121
Fundamentals
- 1-day range
- $2.82$3.5
- Market cap
- $284.27M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 2.94
- Avg. volume
- —
52-week range
$0.2725$4.62
Alpha Tau Medical Ltd. Warrant Competitors
Chosen by industry and closest market cap.
- DRTSWAlpha Tau Medical Ltd. Warrant$2.68▼ 10.37%Market cap $284.27MP/E —$0.2725$4.62
- TMCITreace Medical Concepts Inc. Common Stock$3.87▼ 6.07%Market cap $284.14MP/E —$1.17$7.08
- PROFProfound Medical Corp. Common Stock$6.01▼ 4.75%Market cap $288.52MP/E —$6.52$12.4
- OSUROraSure Technologies Inc. Common Stock$3.61▼ 5.25%Market cap $275.39MP/E —$2.08$4.58
- ANIKAnika Therapeutics Inc. Common Stock$19.98▼ 3.43%Market cap $269.80MP/E —$8.67$22.88
- INFUInfuSystems Holdings Inc. Common Stock$13.4▼ 3.74%Market cap $236.42MP/E 31.71$7.29$13.85
- SENSSenseonics Holdings Inc. Common Stock$7.77▼ 5.59%Market cap $215.29MP/E —$4.79$10.64
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DRTSW Alpha Tau Medical Ltd. Warrant | $284.27M | — | $2.68 | ▼ 10.37% | $0.2725$4.62 |
| TMCI Treace Medical Concepts Inc. Common Stock | $284.14M | — | $3.87 | ▼ 6.07% | $1.17$7.08 |
| PROF Profound Medical Corp. Common Stock | $288.52M | — | $6.01 | ▼ 4.75% | $6.52$12.4 |
| OSUR OraSure Technologies Inc. Common Stock | $275.39M | — | $3.61 | ▼ 5.25% | $2.08$4.58 |
| ANIK Anika Therapeutics Inc. Common Stock | $269.80M | — | $19.98 | ▼ 3.43% | $8.67$22.88 |
| INFU InfuSystems Holdings Inc. Common Stock | $236.42M | 31.71 | $13.4 | ▼ 3.74% | $7.29$13.85 |
| SENS Senseonics Holdings Inc. Common Stock | $215.29M | — | $7.77 | ▼ 5.59% | $4.79$10.64 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Alpha Tau to Participate in October Investor ConferencesYahoo · 10/5/2026
- Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Vistra, Nike to Open HigherYahoo · 10/5/2026
- Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And MoreSeekingAlpha · 9/11/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Alpha Tau Medical to Join October Investor Conferences
Alpha Tau Medical Ltd. will take part in investor conferences scheduled for October, giving analysts a chance to discuss the company's strategy and outlook. The move follows a mixed social media reaction to market openings, with some stocks gaining early momentum. The company's shares trade near the middle of their 52‑week range, and the current RSI suggests moderate momentum.
Alpha Tau Medical to Join October Investor Conferences. Alpha Tau Medical Ltd. will take part in investor conferences scheduled for October, giving analysts a chance to discuss the company's strategy and outlook. The move follows a mixed social media reaction to market openings, with some stocks gaining early momentum. The company's shares trade near the middle of their 52‑week range, and the current RSI suggests moderate momentum.